Brenley Deters, PA-C | |
1060 Meyer Rd, Wentzville, MO 63385-3800 | |
(314) 230-1500 | |
Not Available |
Full Name | Brenley Deters |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 1060 Meyer Rd, Wentzville, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184323586 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 2023010764 (Missouri) | Secondary |
363A00000X | Physician Assistant | 2023010764 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brenley Deters, PA-C 1060 Meyer Rd, Wentzville, MO 63385-3800 Ph: () - | Brenley Deters, PA-C 1060 Meyer Rd, Wentzville, MO 63385-3800 Ph: (314) 230-1500 |
News Archive
Cerus Corporation today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million.
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers have found in a large study that having at least two servings of dairy products can lower the risk of getting diabetes and high blood pressure as well as metabolic syndrome. Metabolic syndrome is a mixture of more than one condition that raises the risk of getting cardiovascular diseases.
Radius Medical, LLC. today announced the FDA clearance and product launch of its new PRODIGY™ Support Catheter. Engineered to provide back up support to the guidewire when encountering difficult to cross lesions, the PRODIGY Support catheter will be a critical component in the revolutionary techniques now being developed in treating chronic total occlusions.
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration today.
› Verified 2 days ago